Fluorodopa FDOPA F 18
- Generic Name: f18 injection
- Brand Name: Fluorodopa FDOPA
Fluorodopa FDOPA(F18 Injection) side effects drug center
Fluorodopa FDOPA F 18 Side Effects Center
What Is Fluorodopa?
Fluorodopa (F18 injection) is a radioactive diagnostic agent used in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Fluorodopa is an adjunct to other diagnostic evaluations.
What Are Side Effects of Fluorodopa?
Side effects of Fluorodopa include:
- injection site pain
Dosage for Fluorodopa
The recommended adult dose of Fluorodopa is 185 megabecquerels (MBq) [5 millicuries (mCi)] by intravenous injection infused over 1 minute.
Fluorodopa In Children
The safety and effectiveness of Fluorodopa for visualization of dopaminergic neurons in the striatum has not been established in pediatric patients.
What Drugs, Substances, or Supplements Interact with Fluorodopa?
Fluorodopa may interact with other medicines such as:
- AADC inhibitors (e.g. carbidopa, benserazide, etc.),
- dopamine agonists,
- dopamine reuptake inhibitors,
- dopamine releasing agents (DRAs),
- peripheral catechol-O-methyltransferase (COMT) inhibitors, and
- monoamine oxidase inhibitors (MAOIs).
Tell your doctor all medications and supplements you use.
Fluorodopa During Pregnancy and Breastfeeding
Tell your doctor if you are pregnant or plan to become pregnant before using Fluorodopa; it may harm a fetus. All radiopharmaceuticals, including Fluorodopa, have a potential to cause fetal harm depending on the stage of fetal development, and the magnitude of the radiation dose. It is unknown if Fluorodopa passes into breast milk. To decrease radiation exposure to a nursing infant, breastfeeding women are advised to pump and discard breastmilk for at least 24 hours (12 half-lives) after administration of Fluorodopa.
Additional Information
Our Fluorodopa (F18 injection) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Fluorodopa FDOPA F 18 Professional Information
SIDE EFFECTS
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. No adverse reactions have been reported for Fluorodopa F 18 Injection based on an open-label clinical trial in 68 patients [see Clinical Studies] and additional clinical experience in 53 patients.
Postmarketing Experience
The following adverse reactions have been identified during post approval of use of Fluorodopa F 18 Injection outside of the United States. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
General Disorders and Administration Site Conditions: Pain
Read the entire FDA prescribing information for Fluorodopa FDOPA F 18 (F18 Injection)
&Copy; Fluorodopa FDOPA F 18 Patient Information is supplied by Cerner Multum, Inc. and Fluorodopa FDOPA F 18 Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.